2-氯-4-甲氧基-5-氨基嘧啶结构式
|
常用名 | 2-氯-4-甲氧基-5-氨基嘧啶 | 英文名 | 5-Amino-2-chloro-4-methoxypyrimidine |
---|---|---|---|---|
CAS号 | 96833-41-9 | 分子量 | 159.57400 | |
密度 | N/A | 沸点 | N/A | |
分子式 | C5H6ClN3O | 熔点 | N/A | |
MSDS | N/A | 闪点 | N/A |
中文名 | 2-氯-4-甲氧基-5-氨基嘧啶 |
---|---|
英文名 | 2-Chloro-4-methoxy-5-pyrimidinamine |
英文别名 | 更多 |
分子式 | C5H6ClN3O |
---|---|
分子量 | 159.57400 |
精确质量 | 159.02000 |
PSA | 61.03000 |
LogP | 1.30200 |
储存条件 | 2-8°C |
~89% 2-氯-4-甲氧基-5-氨基嘧啶 96833-41-9 |
文献:CANCER RESEARCH TECHNOLOGY LIMITED; Bavetsias, Vassilios; Atrash, Butrus; Naud, Sébastien Gaston André; Sheldrake, Peter William; Blagg, Julian Patent: US2013/345181 A1, 2013 ; Location in patent: Paragraph 0785 ; |
~88% 2-氯-4-甲氧基-5-氨基嘧啶 96833-41-9 |
文献:CANCER RESEARCH TECHNOLOGY LIMITED; BAVETSIAS, Vassilios; ATRASH, Butrus; NAUD, Sebastien Gaston Andre; SHELDRAKE, Peter William; BLAGG, Julian Patent: WO2012/123745 A1, 2012 ; Location in patent: Page/Page column 117 ; WO 2012/123745 A1 |
~% 2-氯-4-甲氧基-5-氨基嘧啶 96833-41-9 |
文献:Zeneca Limited Patent: US5861401 A1, 1999 ; |
2-氯-4-甲氧基-5-氨基嘧啶上游产品 3 | |
---|---|
2-氯-4-甲氧基-5-氨基嘧啶下游产品 0 |
5-amino-2-chloro-1-methyl-1H-benzimidazole |
2-chloro-1-methyl-1H-benzoimidazol-5-ylamine |
2-chloropyrimidine-5-ylamine |
5-Amino-2-chloropyrimidine |
2-CHLORO-5-AMINOPYRIMIDINE |
1-methyl-2-chloro-5-aminobenzimidazole |
2-chloro-4-methoxypyrimidine-5-ylamine |
5-amino-2-chloro-4-methoxypyrimidine |
2-Chlor-pyrimidin-5-ylamin |
2-chloro-4-methoxypyrimidin-5-amine |
2-chloropyrimidin-5-ylamine |